Table 8

Outcome features of MRC ALL97/99 and UKALL2003 patients with BCP-ALL and IR cytogenetics stratified according to CNA risk profile

Outcome measuresHR (99% CI), P
ALL97/99UKALL2003
EFS 2.07 (1.31-3.28), .002 5.09 (1.76-14.66), .003 
Relapse risk 2.30 (1.37-3.88), .002 5.45 (1.61-18.43), .006 
OS 2.15 (1.25-3.69), .005 7.19 (1.67-31.01), .008 
Outcome measuresHR (99% CI), P
ALL97/99UKALL2003
EFS 2.07 (1.31-3.28), .002 5.09 (1.76-14.66), .003 
Relapse risk 2.30 (1.37-3.88), .002 5.45 (1.61-18.43), .006 
OS 2.15 (1.25-3.69), .005 7.19 (1.67-31.01), .008 
Close Modal

or Create an Account

Close Modal
Close Modal